Company intelligence / Profile preview
Xiamen Tebao Biological Engineering Co., Ltd.
Xiamen, Fujian, Chinaamoytop.com ↗
- Ownership
- Public · 688278
- Development stage
- Other
01
Overview
Xiamen Tebao Biological Engineering Co., Ltd. ("Tebao Biotech"/"Amoytop") is a leading Chinese biopharmaceutical company focused on recombinant protein drugs, biosimilars such as pegfilgrastim ("Pegneugen®"), cytokines for hepatitis treatment, and more recently advanced therapies including gene therapies using an acquired proprietary AAV vector technology. The company has commercialized products in China with ongoing expansion into new indications and innovative modalities through both internal R&D and strategic acquisitions like that of Skyline Therapeutics' assets in the field of gene therapy.
- Therapeutic areas
- Metabolic DisordersImmunologyHematologyOtherInfectious Diseases
- Modalities
- Recombinant proteins (e.g. cytokines)Biosimilars (e.g. pegfilgrastim)Gene therapy (via AAV platform, post-acquisition of Skyline assets)
- Industry
- Biotech
02
Drug pipeline
20 assets19 more assets in the full pipeline.
03
Partnerships
No major global pharma partnerships disclosed publicly as of May 2025; active in M&A/collaborations within China’s biotech sector
04
Financials
- Market cap
- $2.8B
- Total revenue
- $554.1M
- Enterprise value
- $2.8B
Beyond the preview
Go deeper on Xiamen Tebao Biological Engineering Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiamen Tebao Biological Engineering Co., Ltd..